Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response
Zhigang Kang(National Cancer Institute), Liang Cao(National Institutes of Health)
Cited by 42
Related Papers
Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
|Clinical Cancer Research|2018|415
Genome-Wide Identification of PAX3-FKHR Binding Sites in Rhabdomyosarcoma Reveals Candidate Target Genes Important for Development and Cancer
|Cancer Research|2010|246
Toosendanin Exerts an Anti-Cancer Effect in Glioblastoma by Inducing Estrogen Receptor β- and p53-Mediated Apoptosis
|International Journal of Molecular Sciences|2016|51
<scp>BDNF</scp>‐mediated migration of cardiac microvascular endothelial cells is impaired during ageing
|Journal of Cellular and Molecular Medicine|2012|39